AICDA and Miyoshi myopathy: Based on these data, we hypothesize a novel pathogenic model for MM where aberrant AID activity contributes to tumor initiation, and provides a fertile ground where other later processes (i.e., APOBEC and signature #8) act and shape the final genomic landscape of overt MM.